The point estimates of cumulative CRC incidence at 70 years in that report for both genders combined were 41% for path_MLH1 carriers, 48% for path_MSH2 carriers and 12% for path_MSH6 carriers, very close to the observed incidences in the PLSD series in the current report. This evidence concerns the gene MLH1 and colorectal carcinoma.